MaxCyte, Inc. (MXCT)
1.35
+0.04
(+3.05%)
USD |
NASDAQ |
Nov 06, 10:21
MaxCyte Net Income (Quarterly) : -8.874M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -8.874M |
| March 31, 2026 | -4.75M |
| December 31, 2025 | -9.596M |
| September 30, 2025 | -12.42M |
| June 30, 2025 | -12.36M |
| March 31, 2025 | -10.26M |
| December 31, 2024 | -10.60M |
| September 30, 2024 | -11.56M |
| June 30, 2024 | -9.375M |
| March 31, 2024 | -9.526M |
| December 31, 2023 | -5.277M |
| Date | Value |
|---|---|
| September 30, 2023 | -11.25M |
| June 30, 2023 | -10.51M |
| March 31, 2023 | -10.88M |
| December 31, 2022 | -4.809M |
| September 30, 2022 | -6.434M |
| June 30, 2022 | -8.260M |
| March 31, 2022 | -4.067M |
| December 31, 2021 | -4.874M |
| September 30, 2021 | -2.680M |
| June 30, 2021 | -4.422M |
| March 31, 2021 | -7.106M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Agilent Technologies, Inc. | 362.00M |
| Bio-Rad Laboratories, Inc. | -- |
| Bruker Corp. | -109.70M |
| Azenta, Inc. | -1.529M |
| Danaher Corp. | 1.207B |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 7.271M |
| Total Expenses (Quarterly) | 16.14M |
| EPS Diluted (Quarterly) | -0.0831 |
| Enterprise Value | 50.60M |
| Gross Profit Margin (Quarterly) | 63.86% |
| Profit Margin (Quarterly) | -122.0% |
| Earnings Yield | -24.73% |
| Normalized Earnings Yield | -20.08 |